Influence of P53 on the radiotherapy response of hepatocellular carcinoma
Background/AimsHepatocellular carcinoma (HCC) is one of the most common cancers worldwide, and it has a poor prognosis and few therapeutic options. Radiotherapy is one of the most effective forms of cancer treatment, and P53 protein is one of the key molecules determining how a cell responds to radi...
Main Authors: | Ana R. Gomes, Ana M. Abrantes, Ana F. Brito, Mafalda Laranjo, João E. Casalta-Lopes, Ana C. Gonçalves, Ana B. Sarmento-Ribeiro, Maria F. Botelho, José G. Tralhão |
---|---|
Format: | Article |
Language: | English |
Published: |
Korean Association for the Study of the Liver
2015-09-01
|
Series: | Clinical and Molecular Hepatology |
Subjects: | |
Online Access: | http://e-cmh.org/upload/pdf/cmh-21-257.pdf |
Similar Items
-
P53 expression in hepatocellular carcinoma: influence on the radiotherapeutic response of the hepatocellular carcinoma
by: Yu Rim Lee, et al.
Published: (2015-09-01) -
Targeting hepatocellular carcinoma: what did we discover so far?
by: Ana Filipa Brito, et al.
Published: (2016-10-01) -
Transarterial Radioembolization (TARE) with 131Iodine-Lipiodol for Unresectable Primary Hepatocellular Carcinoma: Experience from a Tertiary Care Center in India
by: Aakash Patel, et al.
Published: (2021-04-01) -
Radiotherapy for metastatic fibrolamellar hepatocellular carcinoma
by: Justin G. Peacock, et al.
Published: (2013-07-01) -
Concurrent Sorafenib and Radiotherapy versus Radiotherapy Alone for Locally Advanced Hepatocellular Carcinoma: A Propensity-Matched Analysis
by: Liu CM, et al.
Published: (2021-08-01)